Jeffrey S. Turner

Statistics

Publications

Citations

1.2K

H-Index

Active since

1998

Affiliations

Oncology Specialists(Current)

Marina Del Rey Hospital

Jeffrey S. Turner is an author at Oncology Specialists specializing in pharmacology, metastatic castration-resistant prostate cancer, and prostate cancer.

Publications per year

1998–2018

Publications

Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils

Jeffrey S. Turner, Yoon Cho, Nhu-Nguyen Dinh et al. · Antimicrobial Agents and Chemotherapy · 1998 · 793 citations · Full text

Life Sciences, Microbiology, Antimicrobial Resistance +13

Evaluation of the Inactivation of Infectious Herpes Simplex Virus by Host-Defense Peptides

Bushra Yasin, Mabel Pang, Jeffrey S. Turner et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2000 · 207 citations

Life Sciences, Infectious Diseases, Molecular Biology +12

Activity of Protegrins against Yeast-Phase <i>Candida albicans</i>

Yoon Cho, Jeffrey S. Turner, Nhu-Nguyen Dinh et al. · Infection and Immunity · 1998 · 69 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer

Mark C. Scholz, Sabrina Yep, Micah Chancey et al. · ImmunoTargets and Therapy · 2017 · 57 citations · Full text

Pharmacy, Oncology, Pharmacology +15

Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer

Jeffrey S. Turner, Uzair B. Chaudhary · Anti-Cancer Drugs · 2009 · 17 citations

Medicine, Oncology, Pharmacology +16

1–5 of 8